Susquehanna International Group’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-28,853
Closed -$227K 13906
2025
Q4
$227K Buy
+28,853
New +$185K ﹤0.01% 10591
2023
Q1
Sell
-29,832
Closed -$345K 13277
2022
Q4
$325K Buy
+29,832
New +$163K ﹤0.01% 8898
2022
Q1
Sell
-33,496
Closed -$323K 13766
2021
Q4
$376K Buy
33,496
+17,041
+104% +$213K ﹤0.01% 9942
2021
Q3
$241K Buy
+16,455
New +$251K ﹤0.01% 11090
2021
Q2
Sell
-23,135
Closed -$430K 13107
2021
Q1
$466K Buy
23,135
+5,602
+32% +$134K ﹤0.01% 9644
2020
Q4
$360K Buy
+17,533
New +$323K ﹤0.01% 8920

Other funds holding PROF

Susquehanna International Group's PROF Position: Q1 2026 in Review

Susquehanna International Group sold out of Profound Medical (PROF) in Q1 2026, closing a stake of 28,853 shares — an estimated $227K sold.

Susquehanna International Group first reported a position in PROF in Q4 2020 and held it in 6 quarters. The position peaked at $466K in Q1 2021. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Susquehanna International Group reported no remaining Profound Medical position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 28,853 Profound Medical shares in Q1 2026, an estimated $227K.
  • Susquehanna International Group first reported a position in Profound Medical in Q4 2020 and held it in 6 quarters.
  • Susquehanna International Group's Profound Medical position peaked at $466K in Q1 2021.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.